fatty-liver

Documents about fatty-liver

• Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements#855860ClinicalTrials.gov
• Plant Sterols and Plant Stanols and Liver Inflammation#864253ClinicalTrials.gov
• A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH#878958ClinicalTrials.gov
• Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients#1009517ClinicalTrials.gov
• The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial#832597ClinicalTrials.gov
• Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease#865396ClinicalTrials.gov
• Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH#903008ClinicalTrials.gov
• Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease#175034ClinicalTrials.gov
• FibroScan-Reproducibility and Repeatability Study#826831ClinicalTrials.gov
• Effects of Carnitine Supplementation on Liver and Muscle#890333ClinicalTrials.gov
• The University of Michigan Wellness for Liver Health Study#904832ClinicalTrials.gov
• Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD#880686ClinicalTrials.gov
• Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness#860514ClinicalTrials.gov
• Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy#314262ClinicalTrials.gov
• Omics-based Predictors of NAFLD/Potential NASH#846234ClinicalTrials.gov
• Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial Between Sleeve Gastrectomy and Gastric Bypass#853244ClinicalTrials.gov
• Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease#895426ClinicalTrials.gov
• Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients#852427ClinicalTrials.gov
• Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults#900463ClinicalTrials.gov
• Liver Disease in Pregnancy#897077ClinicalTrials.gov
• Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study#890662ClinicalTrials.gov
• Non-alcoholic Fatty Liver Disease and Its Treatment#444852ClinicalTrials.gov
• Study on GS300 on NAFLD#861738ClinicalTrials.gov
• C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease#1030103ClinicalTrials.gov
• Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome#915854ClinicalTrials.gov
• Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients#123637ClinicalTrials.gov
• Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes#184802ClinicalTrials.gov
• Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury#641690Dipòsit Digital de la Universitat de Barcelona
• A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease#804870ClinicalTrials.gov
• Effect of a Low AGE Diet on Liver Function in Adults With Fatty Liver.#883936ClinicalTrials.gov
• Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease#307417ClinicalTrials.gov
• Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat#1029960ClinicalTrials.gov
• Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects#287519ClinicalTrials.gov
• Combi-elastography Assessment of Chronic Liver Disease Multi-center Study#866201ClinicalTrials.gov
• Effect of CoQ10 on the Outcome of MAFLD Patients#981632ClinicalTrials.gov
• Chronic Inflammation After Obesity Surgery#1030688ClinicalTrials.gov
• A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease#181667ClinicalTrials.gov
• Analysis of molecular targets and mechanisms of Bisphenol F (BPF)-induced non-alcoholic fatty liver disease (NAFLD) based on network toxicology and molecular dynamics#292687PLOS
• Evaluating the Pharmacokinetics and Safety of Miricorilant#894418ClinicalTrials.gov
• Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members#353387ClinicalTrials.gov
• Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfunction-associated Fatty Liver Disease Patients#893403ClinicalTrials.gov
• NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease#195422ClinicalTrials.gov
• Prevalence of Advanced Fibrosis in Patients Living With HIV#377326ClinicalTrials.gov
• AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.#394738ClinicalTrials.gov
• A Study of JNJ-75220795 in Japanese Participants#897440ClinicalTrials.gov
• UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)#904793ClinicalTrials.gov
• Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study#854307ClinicalTrials.gov
• PNPLA3 I148M drives ferroptosis due to decline of NAD+, predisposing to fatty liver disease#634963eScholarship
• A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver Health#860599ClinicalTrials.gov
• Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)#861205ClinicalTrials.gov